EyeRising and Sky-n1201 reached ANSI group 1 limits within exposure times of 2.8 and 1.4 seconds for a 7-mm pupil.

Light therapy with multiple wavelengths may safely improve vision, reduce new retinal damage, and improve vision related quality of life in patients with dry age related macular degeneration.

The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...

Andy Amadi’s explanation of Blue Therapy is actually kind of beautiful. In a Q&A shared around the Netflix launch, he said the term is defined in the pre-titles as “where calm meets conflict.” He goes ...

CRF awards four global grants to advance CHM research toward new clinical trial endpoints and therapeutic approaches—driving progress toward treatments.

The CMS Innovation Center is approaching the next negotiation cycle for the CGT Access Model. Several considerations will guide the selection of future candidate diseases and potential new model ...

FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...

Phase 3 clinical trial data for AD109 is promising, but the sleep apnea pill might not be the revolution sufferers are looking for. Here's why.

4D Molecular Therapeutics, Inc. ( FDMT) TD Cowen 46th Annual Health Care Conference March 3, 2026 10:30 AM EST ...

Los Angeles artist and criminal justice advocate Mr. Wash has released a new book called Artists in Space to help fund the creation of a community center — including space for art classes and housing ...

Mr Barker says his son has been described by many people as “effortlessly loving”. “You hear how people say they light up a room - he did that,” he said. “Throughout his ...